Endomorphins: Novel endogenous μ-opiate receptor agonists in regions of high μ-opiate receptor density

Annals of the New York Academy of Sciences

Volumn 897, Issue , 1999, Pages 136-144

  Zadina, James E ^a,c   Martin Schild, Sheryl ^c   Gerall, Arnold A ^d   Kastin, Abba J ^a,c   Hackler, Laszlo ^b   Ge, Lin Jun ^a   Zhang, Xing ^b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c TULANE UNIVERSITY   (United States)

^d Tulane University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSAICIN; ENDOMORPHIN 1; ENDOMORPHIN 2; GASTROINTESTINAL AGENT; GUANINE NUCLEOTIDE BINDING PROTEIN; MU OPIATE RECEPTOR; MU OPIATE RECEPTOR AGONIST; NEUROPEPTIDE; SULFUR 35;

ANALGESIC ACTIVITY; CALCIUM CURRENT; CENTRAL NERVOUS SYSTEM; CONFERENCE PAPER; HUMAN; IMMUNOCYTOCHEMISTRY; IMMUNOREACTIVITY; LIGAND BINDING; MEDULLA OBLONGATA; NERVE INJURY; NOCICEPTION; PAIN; RADIOIMMUNOASSAY; RECEPTOR DENSITY; RHIZOTOMY; SENSORY NERVE; SPINAL CORD DORSAL HORN;

EID: 0033380723     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1999.tb07885.x     Document Type: Conference Paper

References (28)

1. 1. Hughes, J., T.W. Smith, H.W. Kosterlitz, L.A. Fothergill, B.A. Morgan & H.R. Morris. 1975. Identification of two related pentapeptides from the brain with potent opiate agonist activity. Nature 258: 577-579.
2. 2. Lord, J.A.H., A.A. Waterfield, J. Hughes & H.W. Kosterlitz. 1977. Endogenous opioid peptides: multiple agonists and receptors. Nature 267: 495-499.
3. 3. Li, C. H. & D. Chung. 1976. Isolation and structure of an untriakontapeptide with opiate activity from camel pituitary glands. Proc. Natl. Acad. Sci. USA 73: 1145-1148.
4. 4. Corbett, A.D., S.J. Paterson & H.W. Kosterlitz. 1993. Selectivity of ligands for opioid receptors. In Opioids I (Handb. Exp. Pharmacol. 104/1). A. Herz, Ed.: 645-679. Springer-Verlag. New York.
5. 5. Goldstein, A., S. Tachibana, L.I. Lowney, M. Hunkapillar & L. Hood. 1979. Dynorphin-(1-13), an extraordinarily potent opioid peptide. Proc. Natl. Acad. Sci. USA 76: 6666-6670.
6. 6. Chavkin, C., I.F. James & A. Goldstein. 1982. Dynorphin is a specific endogenous ligand of the κ opioid receptor. Science 215: 413-415.
7. 7. Pert, C.B. 1973. Opiate receptor: its demonstration in nervous tissue. Science 179: 1011-1014.
8. 8. Matthes, H.W.D., R. Maldonado, F. Simonin, O. Valverde, S. Slowe, I. Kitchen, K. Befort, A. Dierich, M. Le Meur, P. Dolle et al. 1996. Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene. Nature 383: 819-823.
9. 9. Sora, I., N. Takahashi, M. Funada, H. Ujike, R.S. Revay, D.M. Donovan, L.L. Miner & G.R. Uhl. 1997. Opiate receptor knockout mice define μ receptor roles in endogenous nociceptive responses and morphine-induced analgesia. Proc. Natl. Acad. Sci. USA 94: 1544-1549.
10. 10. Zadina, J.E., A.J. Kastin, L.-J. Ge & L. Hackler. 1994. Mu, delta and kappa opiate receptor binding of Tyr-MIF-1 and Tyr-W-MIF-1, its active fragments, and two potent analogs. Life Sci. 55: PL461-466.
11. 11. Henschen, A., F. Lottspeich, V. Brantl & H. Teschemacher. 1979. Novel opioid peptides derived from casein (β-casomorphins). II. Structure of active components from bovine casein peptone. Hoppe-Seyler's Z. Physiol. Chem. 360: 1217-1224.
12. 12. Brantl, V., C. Gramsch, F. Lottspeich, R. Mertz, K.-H. Jaeger & A. Herz. 1986. Novel opioid peptides derived from hemoglobin: hemorphins. Eur. J. Pharmacol. 125: 309-310.
13. 13. Horvath, A. & A.J. Kastin. 1989. Isolation of tyrosine-melanocyte-stimulating hormone release-inhibiting factor 1 from bovine brain tissue. J. Biol. Chem. 264: 2175-2179.
14. 2 (Tyr-W-MIF-1). Peptides 13: 623-631.
15. 15. Zadina, J.E. & A.J. Kastin. 1986. Interactions of Tyr-MIF-1 at opiate receptor sites. Pharmacol. Biochem. Behav. 25: 1303-1305.
16. 16. Zadina, J.E., L. Hackler, L.-G. Ge & A.J. Kastin. 1997. A potent and selective endogenous agonist for the mu opiate receptor. Nature 386: 499-502.
17. 17. Hackler, L., J.E. Zadina, L.-G. Ge & A.J. Kastin. 1997. Isolation of relatively large amounts of endomorphin-1 and endomorphin-2 from human brain cortex. Peptides 18: 1635-1639.
18. 18. Higashida, H., N. Hoshi, R. Knijnik, J.E. Zadina & A.J. Kastin. 1998. Endomorphins inhibit high-threshold Ca2+ channel currents in rodent NG108-15 cells over-expressing μ-opioid receptors. J. Physiol. 507: 71-75.
19. 19. Harrison, L.M., A.J. Kastin & J.E. Zadina. 1998. Differential effects of endomorphin-1, endomorphin-2, and Tyr-W-MIF-1 on activation of G-proteins in SH-SY5Y human neuroblastoma membranes. Peptides 19: 749-753.
20. 20. Martin-Schild, S., J.E. Zadina, A.A. Gerall, S. Vigh & A.J. Kastin. 1997. Localization of endomorphin-2-like immunoreactivity in the rat medulla and spinal cord. Peptides 18: 1641-1649.
21. 21. Arvidsson, U., M. Riedl, S. Chakrabarti, J.-H. Lee, A. Nakano, R.J. Dado, H.H. Loh, P.-Y. Law, M.W. Wessendorf & R. Elde. 1995. Distribution and targeting of a μ-opioid receptor (MOR1) in brain and spinal cord. J. Neurosci. 15: 3328-3341.
22. 22. Martin-Schild, S., A.A. Gerall, A.J. Kastin & J.E. Zadina. 1998. Endomorphin-2 is an endogenous opioid in primary sensory afferent fibers. Peptides 19: 1783-1789.
23. 23. Tuchscherer, M.M. & V.S. Seybold. 1989. A quantitative study of the coexistence of peptides in varicosities within the superficial laminae of the dorsal horn of the rat spinal cord. J. Neurosci. 9: 195-205.
24. 24. Pierce, T.L., M.D. Grahek & M.W. Wessendorf. 1997. Immunoreactivity for endomorphin-2 occurs in primary afferents in rats and monkey. NeuroReport 9: 385-389.
25. 25. Holzer, P. 1991. Capsaicin: Cellular targets, mechanisms of action, and selectivity for thin sensory neurons. Pharmacol. Rev. 43: 143-201.
26. 26. Schreff, M., S. Schulz, D. Wiborny & V. Hollt. 1998. Immunofluorescent identification of endomorphin-2-containing nerve fibers and terminals in the rat brain and spinal cord. NeuroReport 9: 1031-1034.
27. 27. Martin-Schild, S., A.A. Gerall, A.J. Kastin & J.E. Zadina. 1999. Differential distribution of endomorphin 1 - and endomorphin 2-like immunoreactivities in the CNS of the rodent. J. Comp. Neurol. 405: 450-471.
28. 28. Bernard, J.F. & J.M. Besson. 1990. The spino(trigemino)pontoamygdaloid pathway: electrophysiological evidence for an involvement in pain processes. J. Neurophysiol. 63: 473-490.